Rajeev Pathak
banner
drrpathak.bsky.social
Rajeev Pathak
@drrpathak.bsky.social
Cardiac Electrophysiologist and Director Canberra Heart Rhythm | Australian National University | Canberra Hospital | Canberra Heart Rhythm Foundation
Reposted by Rajeev Pathak
NEW! Tune into episode 83 of The Lead!

🎙️ Host: Deepthy Varghese, MSN, ACNP, FNP
🎤 Guests: @tinabaykaner.bsky.social and @jkhmd.bsky.social

Listen on your preferred podcast platform ➡️ bit.ly/40Z6tBh

#EPeeps #medpod #podcast #PodcastAndChill #ArtificialIntelligence #AI #AgePrediction #ECG #EKG
December 5, 2024 at 4:04 PM
Reposted by Rajeev Pathak
NEW! Tune into episode 82 of The Lead!

🎙️ Host: Jason T. Jacobson, MD, FHRS
🎤 Guests: T. Jared Bunch, MD, FHRS and Dominik K Linz, MD, PhD

Listen on your preferred podcast platform ➡️ bit.ly/40Z6tBh

#EPeeps #medpod #podcast #PodcastAndChill #HRS365 #ConductionSystemPacing #BiventricularPacing
November 22, 2024 at 2:40 PM
Reposted by Rajeev Pathak
www.ahajournals.org/doi/10.1161/...

Unfortunately i don’t think CircEP is on #CardioSky yet but an interesting paper looking at PFA or PFA+RFA for SVT. #EPeeps
December 6, 2024 at 2:40 PM
Reposted by Rajeev Pathak
SUMMIT: Among 731 individuals with HFpEF & BMI>30, tirzepatide v placebo led to 38% reduction in CV death / HF events & improvement in symptoms. Interestingly, at least consistent benefit for NTproBNP<200 www.nejm.org/doi/full/10.... @ahascience.bsky.social #AHA24
November 16, 2024 at 3:18 PM
Reposted by Rajeev Pathak
In vivo CRISPR-Cas9 gene editing of TTR among 36 pts w ATTR-CM in ph1 open-label study led to striking consistent reduction in serum TTR level over 12mo. High rate of adverse events reported- likely mix of advanced underlying dz & therapy www.nejm.org/doi/full/10.... @ahascience.bsky.social #AHA24
November 16, 2024 at 3:27 PM
Reposted by Rajeev Pathak
We’re building on 100 years of hope this year at #AH24. The Centennial Experience captures 100 years of #cardiology history, make time for it this weekend at Scientific Sessions. Thank you for joining us and inspiring us into our second century.

🎥: @dramitkhera.bsky.social
November 15, 2024 at 11:22 PM
Reposted by Rajeev Pathak
Most of the time when a pacemaker or ICD lead retracts, or the device itself rotates, it is due to inadequate fixation during the implant procedure. Random arm movements result in ratcheting (preferential unidirectional movement). Occasionally, patients do manipulate devices due to discomfort.
November 16, 2024 at 6:05 PM
Reposted by Rajeev Pathak
#AHA24 officially opened by @dramitkhera.bsky.social

The theme is HOPE! Which is perfect for these 100 years of @American_Heart 🎆
November 16, 2024 at 2:24 PM
Reposted by Rajeev Pathak
#Tirzepatide for Obesity Treatment & Diabetes Prevention
SURMOUNT-1 Trial

✅ Reduced progression to T2DM by 93%
#CardioSky #EndoSky #MedSky #NEJM
www.nejm.org/doi/full/10....
Tirzepatide for Obesity Treatment and Diabetes Prevention | NEJM
Obesity is chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide substantial a...
www.nejm.org
November 14, 2024 at 3:44 AM
Reposted by Rajeev Pathak
It's almost time for #AHA24!
November 14, 2024 at 10:41 PM
Reposted by Rajeev Pathak
#AF burden - under estimated in the Asia-Pacific region - 80M people have AF

Here our collaboration through #APHRS2024

Increase probably due to population size, aging and accumulation of risk factors

www.nature.com/articles/s41...

#CHRD #UofA
November 13, 2024 at 9:13 PM
Reposted by Rajeev Pathak
We will be presenting ARREST-AF as a late breaking clinical trial at #AHA24

Impact of #LRFM on AF ablation outcomes

Look forward to seeing everyone in Chicago
November 11, 2024 at 8:39 PM
Reposted by Rajeev Pathak
Lrfm - lifestyle and risk factor modification - I should have guessed as it’s from Prash Sanders. but not an immediately obvious abbreviation to me…..

Looking forward to seeing more data
November 13, 2024 at 9:47 AM